Concepts (258)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Prostatectomy | 11 | 2021 | 1800 | 1.130 |
Why?
|
| Urology | 3 | 2019 | 368 | 0.970 |
Why?
|
| Urologic Surgical Procedures | 3 | 2019 | 293 | 0.920 |
Why?
|
| Kidney Calices | 2 | 2011 | 21 | 0.770 |
Why?
|
| Laparoscopy | 10 | 2019 | 1981 | 0.700 |
Why?
|
| Robotics | 5 | 2014 | 859 | 0.630 |
Why?
|
| Prostatic Neoplasms | 16 | 2022 | 10525 | 0.610 |
Why?
|
| Kidney Calculi | 3 | 2017 | 441 | 0.600 |
Why?
|
| Nephrostomy, Percutaneous | 2 | 2017 | 82 | 0.570 |
Why?
|
| Nephrectomy | 7 | 2015 | 993 | 0.490 |
Why?
|
| Penile Neoplasms | 2 | 2021 | 158 | 0.480 |
Why?
|
| Urinary Calculi | 1 | 2011 | 80 | 0.430 |
Why?
|
| Varicocele | 1 | 2011 | 73 | 0.430 |
Why?
|
| Blood Loss, Surgical | 1 | 2014 | 667 | 0.390 |
Why?
|
| Electrocoagulation | 1 | 2011 | 180 | 0.390 |
Why?
|
| Diverticulum | 1 | 2011 | 134 | 0.390 |
Why?
|
| Medicine | 1 | 2017 | 851 | 0.390 |
Why?
|
| Urine | 1 | 2011 | 385 | 0.380 |
Why?
|
| Kidney Diseases, Cystic | 1 | 2011 | 180 | 0.380 |
Why?
|
| Blood Transfusion | 2 | 2017 | 1246 | 0.380 |
Why?
|
| Ureter | 2 | 2012 | 360 | 0.360 |
Why?
|
| Nomograms | 1 | 2010 | 225 | 0.360 |
Why?
|
| Clinical Competence | 4 | 2019 | 4615 | 0.350 |
Why?
|
| Ablation Techniques | 1 | 2011 | 230 | 0.340 |
Why?
|
| Testis | 1 | 2011 | 813 | 0.330 |
Why?
|
| Urologic Surgical Procedures, Male | 1 | 2007 | 90 | 0.320 |
Why?
|
| Computer Simulation | 2 | 2019 | 6048 | 0.300 |
Why?
|
| Systemic Inflammatory Response Syndrome | 1 | 2011 | 612 | 0.290 |
Why?
|
| Kidney Neoplasms | 8 | 2015 | 3970 | 0.290 |
Why?
|
| Ureteral Obstruction | 1 | 2007 | 301 | 0.280 |
Why?
|
| Carcinoma, Transitional Cell | 2 | 2022 | 768 | 0.280 |
Why?
|
| Cryosurgery | 3 | 2015 | 408 | 0.280 |
Why?
|
| Prostate-Specific Antigen | 6 | 2021 | 2245 | 0.260 |
Why?
|
| Prostatic Hyperplasia | 2 | 2021 | 511 | 0.250 |
Why?
|
| Neoplasm Recurrence, Local | 8 | 2015 | 8877 | 0.240 |
Why?
|
| Urinary Bladder Neoplasms | 3 | 2022 | 2029 | 0.230 |
Why?
|
| Incidental Findings | 1 | 2007 | 668 | 0.220 |
Why?
|
| Internship and Residency | 4 | 2019 | 5556 | 0.220 |
Why?
|
| Neurilemmoma | 1 | 2007 | 524 | 0.210 |
Why?
|
| Adrenal Gland Neoplasms | 1 | 2007 | 731 | 0.210 |
Why?
|
| Magnetic Resonance Imaging, Interventional | 1 | 2022 | 193 | 0.200 |
Why?
|
| Transurethral Resection of Prostate | 1 | 2021 | 76 | 0.200 |
Why?
|
| Prostate | 5 | 2022 | 1564 | 0.180 |
Why?
|
| Postoperative Complications | 6 | 2017 | 15053 | 0.170 |
Why?
|
| Suture Techniques | 2 | 2014 | 798 | 0.170 |
Why?
|
| Nephrons | 2 | 2014 | 202 | 0.150 |
Why?
|
| Male | 43 | 2022 | 349524 | 0.150 |
Why?
|
| Teaching Rounds | 1 | 2019 | 223 | 0.150 |
Why?
|
| Endoscopy | 2 | 2019 | 1754 | 0.150 |
Why?
|
| Perioperative Period | 1 | 2017 | 262 | 0.150 |
Why?
|
| Cadaver | 1 | 2019 | 1366 | 0.140 |
Why?
|
| Urinary Bladder | 3 | 2022 | 1125 | 0.140 |
Why?
|
| Cystectomy | 3 | 2022 | 628 | 0.140 |
Why?
|
| Lymphatic Metastasis | 2 | 2021 | 2951 | 0.140 |
Why?
|
| Urinary Catheterization | 2 | 2014 | 194 | 0.130 |
Why?
|
| Middle Aged | 31 | 2021 | 213752 | 0.130 |
Why?
|
| Aged | 27 | 2021 | 161488 | 0.130 |
Why?
|
| Hospital Costs | 2 | 2017 | 982 | 0.130 |
Why?
|
| Disease-Free Survival | 4 | 2012 | 7026 | 0.120 |
Why?
|
| Calculi | 1 | 2013 | 44 | 0.120 |
Why?
|
| Treatment Outcome | 12 | 2022 | 61932 | 0.120 |
Why?
|
| Hematocrit | 1 | 2014 | 636 | 0.120 |
Why?
|
| Time Factors | 10 | 2015 | 41038 | 0.120 |
Why?
|
| Biopsy | 3 | 2015 | 6766 | 0.120 |
Why?
|
| Kidney | 3 | 2014 | 6888 | 0.120 |
Why?
|
| Brachytherapy | 1 | 2021 | 1298 | 0.120 |
Why?
|
| Humans | 47 | 2022 | 708843 | 0.120 |
Why?
|
| Databases, Factual | 3 | 2017 | 7763 | 0.110 |
Why?
|
| Ureteroscopes | 1 | 2012 | 18 | 0.110 |
Why?
|
| Circumcision, Male | 1 | 2013 | 152 | 0.110 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2007 | 3876 | 0.110 |
Why?
|
| Educational Measurement | 1 | 2019 | 1271 | 0.110 |
Why?
|
| Electrosurgery | 1 | 2011 | 58 | 0.110 |
Why?
|
| Blood Coagulation Disorders | 1 | 2014 | 341 | 0.110 |
Why?
|
| Competency-Based Education | 1 | 2013 | 232 | 0.110 |
Why?
|
| Logistic Models | 4 | 2017 | 13468 | 0.110 |
Why?
|
| Surgery, Computer-Assisted | 1 | 2019 | 1018 | 0.110 |
Why?
|
| Ergocalciferols | 1 | 2012 | 119 | 0.110 |
Why?
|
| Renal Insufficiency, Chronic | 3 | 2014 | 1938 | 0.100 |
Why?
|
| Lithotripsy | 1 | 2011 | 139 | 0.100 |
Why?
|
| Lacerations | 1 | 2012 | 137 | 0.100 |
Why?
|
| Kidney Pelvis | 1 | 2011 | 182 | 0.100 |
Why?
|
| Carcinoma, Renal Cell | 3 | 2011 | 2910 | 0.100 |
Why?
|
| Intraoperative Period | 1 | 2011 | 538 | 0.100 |
Why?
|
| Disease Progression | 3 | 2011 | 13298 | 0.100 |
Why?
|
| Gels | 1 | 2011 | 438 | 0.100 |
Why?
|
| Urologic Neoplasms | 1 | 2014 | 316 | 0.100 |
Why?
|
| Work Schedule Tolerance | 1 | 2014 | 560 | 0.100 |
Why?
|
| Learning Curve | 1 | 2011 | 202 | 0.100 |
Why?
|
| Sus scrofa | 1 | 2011 | 455 | 0.100 |
Why?
|
| Kidney Cortex | 1 | 2009 | 188 | 0.100 |
Why?
|
| Computer-Assisted Instruction | 1 | 2013 | 379 | 0.090 |
Why?
|
| Urography | 1 | 2011 | 326 | 0.090 |
Why?
|
| Tissue Kallikreins | 1 | 2009 | 15 | 0.090 |
Why?
|
| Preoperative Period | 1 | 2011 | 552 | 0.090 |
Why?
|
| Psychomotor Performance | 2 | 2014 | 1938 | 0.090 |
Why?
|
| Electrodes | 1 | 2011 | 590 | 0.090 |
Why?
|
| Lymph Node Excision | 2 | 2021 | 1179 | 0.090 |
Why?
|
| Organ Size | 2 | 2011 | 2317 | 0.090 |
Why?
|
| Retrospective Studies | 15 | 2022 | 71483 | 0.090 |
Why?
|
| Endpoint Determination | 1 | 2011 | 623 | 0.090 |
Why?
|
| Intraoperative Complications | 1 | 2015 | 1192 | 0.080 |
Why?
|
| Neoplasm Staging | 3 | 2012 | 11126 | 0.080 |
Why?
|
| Regional Blood Flow | 1 | 2011 | 1580 | 0.080 |
Why?
|
| User-Computer Interface | 1 | 2014 | 1433 | 0.080 |
Why?
|
| Odds Ratio | 3 | 2017 | 9754 | 0.080 |
Why?
|
| Fatigue | 1 | 2014 | 1450 | 0.080 |
Why?
|
| Dyspnea | 1 | 2014 | 1237 | 0.080 |
Why?
|
| Stress, Mechanical | 1 | 2012 | 1714 | 0.080 |
Why?
|
| Aged, 80 and over | 11 | 2015 | 58184 | 0.070 |
Why?
|
| Salvage Therapy | 1 | 2013 | 1296 | 0.070 |
Why?
|
| Adult | 17 | 2022 | 211041 | 0.070 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2019 | 3984 | 0.070 |
Why?
|
| SEER Program | 1 | 2011 | 1549 | 0.070 |
Why?
|
| Prognosis | 6 | 2012 | 28919 | 0.070 |
Why?
|
| Epidemiologic Methods | 1 | 2010 | 1346 | 0.070 |
Why?
|
| Biopsy, Needle | 2 | 2007 | 1682 | 0.070 |
Why?
|
| United States | 8 | 2021 | 67165 | 0.070 |
Why?
|
| Ultrasonography, Doppler | 1 | 2007 | 466 | 0.070 |
Why?
|
| Female | 22 | 2022 | 375205 | 0.060 |
Why?
|
| Vitamins | 1 | 2012 | 1466 | 0.060 |
Why?
|
| Pain, Postoperative | 1 | 2014 | 1599 | 0.060 |
Why?
|
| Pain Measurement | 1 | 2014 | 3510 | 0.060 |
Why?
|
| Multivariate Analysis | 3 | 2012 | 12447 | 0.060 |
Why?
|
| Endosonography | 1 | 2007 | 573 | 0.060 |
Why?
|
| General Surgery | 1 | 2014 | 1645 | 0.060 |
Why?
|
| Receptors, Androgen | 1 | 2009 | 1060 | 0.060 |
Why?
|
| Perioperative Care | 1 | 2011 | 1067 | 0.060 |
Why?
|
| Venous Thromboembolism | 1 | 2014 | 1537 | 0.060 |
Why?
|
| Education, Medical | 1 | 2014 | 1683 | 0.060 |
Why?
|
| Ischemia | 1 | 2011 | 1934 | 0.060 |
Why?
|
| Suprachiasmatic Nucleus | 1 | 2003 | 150 | 0.060 |
Why?
|
| Survival Rate | 4 | 2012 | 13202 | 0.060 |
Why?
|
| Vitamin D Deficiency | 1 | 2012 | 1356 | 0.060 |
Why?
|
| Follow-Up Studies | 4 | 2012 | 39038 | 0.050 |
Why?
|
| Inguinal Canal | 1 | 2021 | 72 | 0.050 |
Why?
|
| Curriculum | 1 | 2014 | 3329 | 0.050 |
Why?
|
| Forecasting | 1 | 2010 | 2941 | 0.050 |
Why?
|
| NF-kappa B | 1 | 2009 | 2563 | 0.050 |
Why?
|
| Glomerular Filtration Rate | 3 | 2014 | 2090 | 0.050 |
Why?
|
| Incidence | 5 | 2021 | 20320 | 0.040 |
Why?
|
| Hypothalamo-Hypophyseal System | 1 | 2003 | 660 | 0.040 |
Why?
|
| Calcium | 1 | 2012 | 5825 | 0.040 |
Why?
|
| Ultrasonography | 1 | 2011 | 5918 | 0.040 |
Why?
|
| Analgesics, Opioid | 1 | 2014 | 3308 | 0.040 |
Why?
|
| Neoplasm Invasiveness | 2 | 2022 | 3693 | 0.040 |
Why?
|
| Watchful Waiting | 1 | 2021 | 451 | 0.040 |
Why?
|
| Prevalence | 2 | 2011 | 14712 | 0.040 |
Why?
|
| Muscles | 1 | 2022 | 1622 | 0.040 |
Why?
|
| Ureteral Calculi | 1 | 2017 | 103 | 0.040 |
Why?
|
| Prospective Studies | 5 | 2017 | 50597 | 0.040 |
Why?
|
| Tumor Burden | 2 | 2014 | 1906 | 0.040 |
Why?
|
| Predictive Value of Tests | 5 | 2011 | 15252 | 0.030 |
Why?
|
| Preoperative Care | 3 | 2011 | 2357 | 0.030 |
Why?
|
| Codeine | 1 | 2014 | 44 | 0.030 |
Why?
|
| Models, Biological | 1 | 2011 | 9907 | 0.030 |
Why?
|
| Urinary Bladder Calculi | 1 | 2013 | 13 | 0.030 |
Why?
|
| Ultrasonography, Interventional | 1 | 2022 | 1480 | 0.030 |
Why?
|
| Risk Factors | 7 | 2015 | 69553 | 0.030 |
Why?
|
| Cystitis | 1 | 2013 | 86 | 0.030 |
Why?
|
| Area Under Curve | 2 | 2009 | 1688 | 0.030 |
Why?
|
| Statistics, Nonparametric | 2 | 2012 | 2945 | 0.030 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2022 | 3515 | 0.030 |
Why?
|
| Adolescent | 2 | 2011 | 84718 | 0.030 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2009 | 8638 | 0.030 |
Why?
|
| Constriction | 1 | 2011 | 176 | 0.030 |
Why?
|
| Hematuria | 1 | 2013 | 235 | 0.030 |
Why?
|
| Swine | 2 | 2012 | 5763 | 0.030 |
Why?
|
| Cautery | 1 | 2011 | 61 | 0.030 |
Why?
|
| Young Adult | 3 | 2014 | 55940 | 0.030 |
Why?
|
| Circadian Rhythm | 1 | 2003 | 2533 | 0.030 |
Why?
|
| Motivation | 1 | 2021 | 1868 | 0.030 |
Why?
|
| Neoadjuvant Therapy | 1 | 2022 | 2561 | 0.030 |
Why?
|
| Surgical Instruments | 1 | 2013 | 409 | 0.020 |
Why?
|
| Age Factors | 3 | 2015 | 18712 | 0.020 |
Why?
|
| Acetaminophen | 1 | 2014 | 540 | 0.020 |
Why?
|
| Feedback | 1 | 2013 | 747 | 0.020 |
Why?
|
| alpha-Amylases | 1 | 1989 | 38 | 0.020 |
Why?
|
| Sodium Chloride | 1 | 2011 | 640 | 0.020 |
Why?
|
| Risk Assessment | 3 | 2021 | 23284 | 0.020 |
Why?
|
| Sex Factors | 2 | 2015 | 10566 | 0.020 |
Why?
|
| Hand | 1 | 2014 | 860 | 0.020 |
Why?
|
| Drug Combinations | 1 | 2014 | 1925 | 0.020 |
Why?
|
| Pilot Projects | 2 | 2011 | 7994 | 0.020 |
Why?
|
| Sesquiterpenes | 1 | 2009 | 181 | 0.020 |
Why?
|
| Catheterization | 1 | 2014 | 1463 | 0.020 |
Why?
|
| Transcription Factor RelA | 1 | 2009 | 291 | 0.020 |
Why?
|
| Electric Impedance | 1 | 2011 | 657 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2022 | 34151 | 0.020 |
Why?
|
| Reference Values | 1 | 2015 | 5041 | 0.020 |
Why?
|
| Intraoperative Care | 1 | 2011 | 783 | 0.020 |
Why?
|
| Necrosis | 1 | 2011 | 1646 | 0.020 |
Why?
|
| Abdominal Pain | 1 | 2014 | 1019 | 0.020 |
Why?
|
| Nuclear Proteins | 1 | 2003 | 5982 | 0.020 |
Why?
|
| Regression Analysis | 1 | 2017 | 6451 | 0.020 |
Why?
|
| Sodium | 1 | 2012 | 1637 | 0.020 |
Why?
|
| Checklist | 1 | 2013 | 781 | 0.020 |
Why?
|
| Obesity | 1 | 2008 | 12031 | 0.020 |
Why?
|
| Radiotherapy | 1 | 2013 | 1623 | 0.020 |
Why?
|
| Parathyroid Hormone | 1 | 2012 | 1819 | 0.020 |
Why?
|
| Clinical Trials as Topic | 1 | 2021 | 8024 | 0.020 |
Why?
|
| Models, Animal | 1 | 2011 | 2221 | 0.020 |
Why?
|
| Postoperative Care | 1 | 2011 | 1514 | 0.020 |
Why?
|
| Critical Care | 1 | 2017 | 2473 | 0.020 |
Why?
|
| Saliva | 1 | 1989 | 793 | 0.020 |
Why?
|
| Hospitals | 1 | 2017 | 3290 | 0.020 |
Why?
|
| Protein Isoforms | 1 | 2009 | 1712 | 0.020 |
Why?
|
| Autopsy | 1 | 2007 | 990 | 0.020 |
Why?
|
| Medicare | 1 | 2021 | 5691 | 0.020 |
Why?
|
| Health Care Costs | 1 | 2017 | 3152 | 0.020 |
Why?
|
| Length of Stay | 1 | 2017 | 6257 | 0.020 |
Why?
|
| Cohort Studies | 3 | 2011 | 39292 | 0.020 |
Why?
|
| Child | 1 | 2011 | 73636 | 0.020 |
Why?
|
| Reoperation | 1 | 2013 | 4159 | 0.020 |
Why?
|
| Comorbidity | 1 | 2017 | 10339 | 0.010 |
Why?
|
| Period Circadian Proteins | 1 | 2003 | 102 | 0.010 |
Why?
|
| Fasting | 1 | 1989 | 1608 | 0.010 |
Why?
|
| Mice, Nude | 1 | 2009 | 3859 | 0.010 |
Why?
|
| Treatment Failure | 1 | 2008 | 2680 | 0.010 |
Why?
|
| Body Composition | 1 | 2011 | 2393 | 0.010 |
Why?
|
| Linear Models | 1 | 2012 | 5986 | 0.010 |
Why?
|
| Probability | 1 | 2007 | 2474 | 0.010 |
Why?
|
| Neurosecretory Systems | 1 | 2003 | 238 | 0.010 |
Why?
|
| Hospital Mortality | 1 | 2015 | 5095 | 0.010 |
Why?
|
| ROC Curve | 1 | 2009 | 3518 | 0.010 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2009 | 3714 | 0.010 |
Why?
|
| Animals | 5 | 2012 | 170486 | 0.010 |
Why?
|
| Neoplasm Metastasis | 1 | 2011 | 5112 | 0.010 |
Why?
|
| Luminescent Proteins | 1 | 2003 | 885 | 0.010 |
Why?
|
| Transgenes | 1 | 2003 | 1026 | 0.010 |
Why?
|
| Socioeconomic Factors | 1 | 2012 | 7644 | 0.010 |
Why?
|
| Reconstructive Surgical Procedures | 1 | 2011 | 2137 | 0.010 |
Why?
|
| Vitamin D | 1 | 2012 | 3138 | 0.010 |
Why?
|
| Hospitalization | 1 | 2017 | 9644 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 1 | 2009 | 6068 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2015 | 19423 | 0.010 |
Why?
|
| Green Fluorescent Proteins | 1 | 2003 | 2193 | 0.010 |
Why?
|
| Glucose | 1 | 1989 | 4261 | 0.010 |
Why?
|
| Microscopy, Confocal | 1 | 2003 | 2046 | 0.010 |
Why?
|
| Registries | 1 | 2011 | 7989 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2013 | 24433 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2009 | 10803 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2009 | 16959 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2007 | 14836 | 0.010 |
Why?
|
| Research Design | 1 | 2007 | 5833 | 0.010 |
Why?
|
| Diabetes Mellitus | 1 | 1989 | 5348 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2009 | 21194 | 0.010 |
Why?
|
| Cell Cycle Proteins | 1 | 2003 | 3507 | 0.010 |
Why?
|
| Body Mass Index | 1 | 2008 | 12366 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2008 | 16008 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2003 | 9927 | 0.010 |
Why?
|
| Mice | 2 | 2009 | 80876 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2003 | 11790 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2003 | 13314 | 0.000 |
Why?
|
| Antineoplastic Agents | 1 | 2009 | 13714 | 0.000 |
Why?
|
| Glucose Tolerance Test | 1 | 1989 | 1156 | 0.000 |
Why?
|
| Gene Expression Regulation | 1 | 2003 | 12447 | 0.000 |
Why?
|
| Neurons | 1 | 2003 | 9385 | 0.000 |
Why?
|
Concepts
(258)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(19)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_